Industrial, Manufacturing & Heavy Industry Market News

Global point of care testing market to reach $35.3 billion by 2024

The Global point-of-care testing market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

- Advertising -

The market of Global Point-Of-Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report @ databridgemarketresearch.com/request-a-sample/?dbmr=global-cord-stem-cell-banking-market Point-of-Care Testing (POCT) Market – Market Segmentation:

By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others), Prescription Mode (Prescription Based Testing & Over-The-Counter Testing), Distribution Channel (Direct Tenders & Retail), End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), Geography (North America, Europe, Asia-Pacific, South America, Rest of the World).

- Advertising -

Basis of product, the market is segmented into 13 major segments, which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.

Based on prescription mode, the global point-of-care testing market is segmented into prescription based testing and over-the-counter (OTC) testing.

Browse Full Report with Details TOC @ databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market/ Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

Some of the major players operating in this market are

  1. Siemens AG
  2. Abbott Laboratories, Inc.
  3. Beckman Coulter, Inc
  4. Becton
  5. Dickinson and Company
  6. Johnson & Johnson
  7. Alere Inc.
  8. Instrumentation Laboratory
  9. PTS Diagnostics
  10. Abaxis, Inc.
  11. Medtronic
  12. Accriva Diagnostics
  13. OPTI Medical
  14. Sienco, Inc.
  15. Alpha Scientific
  16. AccuBioTech Co., Ltd.
  17. ACON Laboratories, Inc.
  18. Acrongenomics, Inc.
  19. bioMérieux SA
  20. Biomerica, Inc.
  21. Atlas Genetics Ltd.
  22. Alfa Scientific Designs, Inc.
  23. Bio-Rad Laboratories, Inc.
  24. Medica Corporation
  25. Nova Biomedical

Enquire about report @ databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market Table Of Content:

  1. INTRODUCTION

1.1. OVERVIEW OF THE GLOBAL POINT-OF-CARE TESTING MARKET

1.2. MARKET SEGMENTATION & COVERAGE

1.2.1. CURRENCY AND PRICING

1.2.2. LIMITATION

1.2.3. STAKEHOLDERS

  1. RESEARCH METHODOLOGY

2.1. KEY TAKEAWAYS

2.2. ARRIVING AT THE GLOBAL POINT-OF-CARE TESTING MARKET SIZE

2.2.1. MARKET CRACKDOWN APPROACH

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3. DATA TRIANGULATION

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5. PRODUCT PIPELINE ANALYSIS

2.2.6. PORTER’S FIVE FORCES MATRIX

2.3. GLOBAL POINT-OF-CARE TESTING MARKET: RESEARCH SNAPSHOT

2.4. ASSUMPTIONS

  1. MARKET LANDSCAPE SUMMARY
  2. PREMIUM INSIGHTS

4.1. OVERVIEW

4.2. GLOBAL POINT-OF-CARE TESTING MARKET: KEY PRIMARY INSIGHTS

4.3. MARKET OVERVIEW

4.3.1. DRIVERS

4.3.1.1. HIGH PREVALENCE OF INFECTIOUS DISEASES IN DEVELOPING COUNTRIES

4.3.1.2. INCREASING INCIDENCE OF LIFESTYLE DISEASES

4.3.1.3. RISING USAGE OF HOME-BASED POC DEVICES

4.3.1.4. GROWING NUMBER OF REGULATORY APPROVALS FOR NOVEL IMMUNOASSAY TECHNIQUES

4.3.1.5. SHORTAGE OF SKILLED LABORATORY TECHNICIANS INCREASING PREFERENCE OF POC TESTING

4.3.1.6. RISING INCIDENCE OF UNPLANNED PREGANANCIES

4.3.2. RESTRAINTS

4.3.3. OPPURTUNITIES

4.3.4. THREATS

4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

  1. POINT-OF-CARE TESTING MARKET, BY TYPE

5.1. OVERVIEW

5.2. CARDIOMETABOLIC MONITORING KITS, BY PRODUCT TYPE

5.2.1. CARDIAC MARKERS

5.2.2. BLOOD GAS ELECTROLYTE TESTING KITS

5.2.3. HBA1C TESTING KITS

5.2.4. LIPID TESTING KITS

5.3. INFECTIOUS DISEASE TESTING KITS, BY PRODUCT TYPE

5.3.1. INFLUENZA TESTING KITS

5.3.2. HIV TESTING KITS

5.3.3. HEPATITIS C TESTING KITS

5.3.4. STD TESTING KITS

5.3.5. TROPICAL DISEASE TESTING KITS

5.3.6. HEALTHCARE ASSOCIATED INFECTIONS TESTING KITS

5.3.7. RESPIRATORY INFECTIONS TESTING KITS

5.3.8. OTHERS

5.4. CHOLESTROL TESTING KITS, BY PRODUCT TYPE

5.4.1. PROTHROMBIN TIME TESTING KITS

5.4.2. ACTIVATED CLOTTING TIME TESTING KITS

5.5. BLOOD GLUCOSE TESTING KITS

5.6. PREGNANCY AND FERTILITY TESTING KITS

5.7. TUMOR CANCER MARKERS

5.8. URINALYSIS TESTING KITS

5.9. HEMATOLOGY TESTING KITS

5.10. DRUGS OF ABUSE TESTING KITS

5.11. FECAL OCCULT TESTING KITS

5.12. RAPID COAGULATION TESTING KITS

5.13. OTHERS

  1. POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

6.1. OVERVIEW

6.2. PRESCRIPTION BASED TESTING KITS

6.3. OVER THE COUNTER (OTC) BASED TESTING KITS

  1. POINT-OF-CARE TESTING MARKET, BY END-USER

7.1. OVERVIEW

7.2. HOSPITALS

7.3. CLINICS

7.4. AMBULATORY CARE

7.5. HOME HEALTHCARE

7.6. RESEARCH LABORATORY

  1. POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

8.1. OVERVIEW

8.2. DIRECT TENDERS

8.3. RETAIL

  1. POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY

9.1. COUNTRYWISE POINT OF CARE TESTING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1. NORTH AMERICA

9.1.1.1. U.S.

9.1.1.2. CANADA

9.1.1.3. MEXICO

9.1.2. EUROPE

9.1.2.1. GERMANY

9.1.2.2. FRANCE

9.1.2.3. U.K.

9.1.2.4. ITALY

9.1.2.5. SPAIN

9.1.2.6. RUSSIA

9.1.2.7. TURKEY

9.1.2.8. BELGIUM

9.1.2.9. NETHERLANDS

9.1.2.10. SWITZERLAND

9.1.2.11. REST OF EUROPE

9.1.3. ASIA-PACIFIC (APAC)

9.1.3.1. JAPAN

9.1.3.2. CHINA

9.1.3.3. SOUTH KOREA

9.1.3.4. INDIA

9.1.3.5. AUSTRALIA

9.1.3.6. SINGAPORE

9.1.3.7. THAILAND

9.1.3.8. MALAYSIA

9.1.3.9. INDONESIA

9.1.3.10. PHILIPPINES

9.1.3.11. REST OF APAC

9.1.4. LATIN AMERICA

9.1.4.1. BRAZIL

9.1.4.2. REST OF LATIN AMERICA

9.1.5. MIDDLE EAST AND AFRICA

9.1.5.1. SOUTH AFRICA

9.1.5.2. REST OF MIDDLE EAST AND AFRICA

9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. POINT-OF-CARE TESTING MARKET: COMPETITIVE LANDSCAPE

10.1. GLOBAL POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS

10.2. U.S. POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS

10.3. EUROPE POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS

10.4. APAC POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS

10.5. SOUTH AMERICA POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS

10.6. MEA POINT OF CARE TESTING MARKET: COMPANY SHARE ANALYSIS

10.7. MERGERS & ACQUISITIONS

10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

10.9. EXPANSIONS

10.10. REGULATORY CHANGES

10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

  1. POINT-OF-CARE TESTING MARKET: COMPANY PROFILES

11.1. ABBOTT LABORATORIES, INC.

11.1.1   COMPANY OVERVIEW

11.1.2   SWOT ANALYSIS

11.1.3   REVENUE ANALYSIS

11.1.4   PRODUCT PORTFOLIO

11.1.5   RECENT DEVELOPEMENTS

11.1.6   DATA BRIDGE ANALYSIS

11.2. ROCHE DIAGNOSTICS LIMITED

11.2.1   COMPANY OVERVIEW

11.2.2   SWOT ANALYSIS

11.2.3   REVENUE ANALYSIS

11.2.4   PRODUCT PORTFOLIO

11.2.5   RECENT DEVELOPEMENTS

11.2.6   DATA BRIDGE ANALYSIS

11.3. SIEMENS AG

11.3.1   COMPANY OVERVIEW

11.3.2   SWOT ANALYSIS

11.3.3   REVENUE ANALYSIS

11.3.4   PRODUCT PORTFOLIO

11.3.5   RECENT DEVELOPEMENTS

11.3.6   DATA BRIDGE ANALYSIS

11.4. BECKMAN COULTER, INC.

11.4.1   COMPANY OVERVIEW

11.4.2   SWOT ANALYSIS

11.4.3   REVENUE ANALYSIS

11.4.4   PRODUCT PORTFOLIO

11.4.5   RECENT DEVELOPEMENTS

11.4.6   DATA BRIDGE ANALYSIS

11.5. BECTON, DICKINSON AND COMPANY

11.5.1   COMPANY OVERVIEW

11.5.2   SWOT ANALYSIS

11.5.3   REVENUE ANALYSIS

11.5.4   PRODUCT PORTFOLIO

11.5.5   RECENT DEVELOPEMENTS

11.5.6   DATA BRIDGE ANALYSIS

11.6. JOHNSON & JOHNSON

11.6.1   COMPANY OVERVIEW

11.6.2   SWOT ANALYSIS

11.6.3   REVENUE ANALYSIS

11.6.4   PRODUCT PORTFOLIO

11.6.5   RECENT DEVELOPEMENTS

11.6.6   DATA BRIDGE ANALYSIS

11.7. ALERE INC.

11.7.1   COMPANY OVERVIEW

11.7.2   SWOT ANALYSIS

11.7.3   REVENUE ANALYSIS

11.7.4   PRODUCT PORTFOLIO

11.7.5   RECENT DEVELOPEMENTS

11.7.6   DATA BRIDGE ANALYSIS

11.8. INSTRUMENTATION LABORATORY

11.8.1   COMPANY OVERVIEW

11.8.2   SWOT ANALYSIS

11.8.3   REVENUE ANALYSIS

11.8.4   PRODUCT PORTFOLIO

11.8.5   RECENT DEVELOPEMENTS

11.8.6   DATA BRIDGE ANALYSIS

11.9. PTS DIAGNOSTICS

11.9.1   COMPANY OVERVIEW

11.9.2   SWOT ANALYSIS

11.9.3   REVENUE ANALYSIS

11.9.4   PRODUCT PORTFOLIO

11.9.5   RECENT DEVELOPEMENTS

11.9.6   DATA BRIDGE ANALYSIS

11.10. ABAXIS, INC.

11.10.1   COMPANY OVERVIEW

11.10.2   SWOT ANALYSIS

11.10.3   REVENUE ANALYSIS

11.10.4   PRODUCT PORTFOLIO

11.10.5   RECENT DEVELOPEMENTS

11.10.6   DATA BRIDGE ANALYSIS

11.11. MEDTRONIC

11.11.1   COMPANY OVERVIEW

11.11.2   SWOT ANALYSIS

11.11.3   REVENUE ANALYSIS

11.11.4   PRODUCT PORTFOLIO

11.11.5   RECENT DEVELOPEMENTS

11.11.6   DATA BRIDGE ANALYSIS

11.12. ACCRIVA DIAGNOSTICS

11.12.1   COMPANY OVERVIEW

11.12.2   SWOT ANALYSIS

11.12.3   REVENUE ANALYSIS

11.12.4   PRODUCT PORTFOLIO

11.12.5   RECENT DEVELOPEMENTS

11.12.6   DATA BRIDGE ANALYSIS

11.13. OPTI MEDICAL

11.13.1   COMPANY OVERVIEW

11.13.2   SWOT ANALYSIS

11.13.3   REVENUE ANALYSIS

11.13.4   PRODUCT PORTFOLIO

11.13.5   RECENT DEVELOPEMENTS

11.13.5   DATA BRIDGE ANALYSIS

11.14. SIENCO, INC.

11.14.1   COMPANY OVERVIEW

11.14.2   SWOT ANALYSIS

11.14.3   REVENUE ANALYSIS

11.14.4   PRODUCT PORTFOLIO

11.14.5   RECENT DEVELOPEMENTS

11.14.6   DATA BRIDGE ANALYSIS

11.15. ALPHA SCIENTIFIC

11.15.1   COMPANY OVERVIEW

11.15.2   SWOT ANALYSIS

11.15.3   REVENUE ANALYSIS

11.15.4   PRODUCT PORTFOLIO

11.15.5   RECENT DEVELOPEMENTS

11.15.6   DATA BRIDGE ANALYSIS

11.16. ACCUBIOTECH CO. LTD.

11.16.1   COMPANY OVERVIEW

11.16.2   SWOT ANALYSIS

11.16.3   REVENUE ANALYSIS

11.16.4   PRODUCT PORTFOLIO

11.16.5   RECENT DEVELOPEMENTS

11.16.5   DATA BRIDGE ANALYSIS

11.17. ACON LABORATORIES, INC.

11.17.1   COMPANY OVERVIEW

11.17.2   SWOT ANALYSIS

11.17.3   REVENUE ANALYSIS

11.17.4   PRODUCT PORTFOLIO

11.17.5   RECENT DEVELOPEMENTS

11.17.6   DATA BRIDGE ANALYSIS

11.18. ACRONGENOMICS

11.18.1   COMPANY OVERVIEW

11.18.2   SWOT ANALYSIS

11.18.3   REVENUE ANALYSIS

11.18.4   PRODUCT PORTFOLIO

11.18.5   RECENT DEVELOPEMENTS

11.18.6   DATA BRIDGE ANALYSIS

11.19. BIOMÉRIEUX, BIOMERICA, INC.

11.19.1   COMPANY OVERVIEW

11.19.2   SWOT ANALYSIS

11.19.3   REVENUE ANALYSIS

11.19.4   PRODUCT PORTFOLIO

11.19.5   RECENT DEVELOPEMENTS

11.19.6   DATA BRIDGE ANALYSIS

11.20. ATLAS GENETICS LTD.

11.20.1   COMPANY OVERVIEW

11.20.2   SWOT ANALYSIS

11.20.3   REVENUE ANALYSIS

11.20.4   PRODUCT PORTFOLIO

11.20.5   RECENT DEVELOPEMENTS

11.20.6   DATA BRIDGE ANALYSIS

11.21. ALFA SCIENTIFIC DESIGNS, INC.

11.21.1   COMPANY OVERVIEW

11.21.2   SWOT ANALYSIS

11.21.3   REVENUE ANALYSIS

11.21.4   PRODUCT PORTFOLIO

11.21.5   RECENT DEVELOPEMENTS

11.21.6   DATA BRIDGE ANALYSIS

11.22. BIO-RAD LABORATORIES, INC.

11.22.1   COMPANY OVERVIEW

11.22.2   SWOT ANALYSIS

11.22.3   REVENUE ANALYSIS

11.22.4   PRODUCT PORTFOLIO

11.22.5   RECENT DEVELOPEMENTS

11.22.6   DATA BRIDGE ANALYSIS

11.23. MEDICA CORPORATION

11.23.1   COMPANY OVERVIEW

11.23.2   SWOT ANALYSIS

11.23.3   REVENUE ANALYSIS

11.23.4   PRODUCT PORTFOLIO

11.23.5   RECENT DEVELOPEMENTS

11.23.6   DATA BRIDGE ANALYSIS

11.24. NOVA BIOMEDICAL

11.24.1   COMPANY OVERVIEW

11.24.2   SWOT ANALYSIS

11.24.3   REVENUE ANALYSIS

11.24.4   PRODUCT PORTFOLIO

11.24.5   RECENT DEVELOPEMENTS

11.24.6   DATA BRIDGE ANALYSIS

  1. APPENDIX

12.1. SOURCES AND BIBLIOGRAPHY

12.2. RELATED REPORTS

12.3. A GLIMSE OF DATA BRIDGE MARKET RESEARCH FACTBOOK

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...